Hodges MR, Tawadrous M, Cornely OA, Thompson GR 3rd, et al. Fosmanogepix for the Treatment of Invasive Mold Diseases Caused by Aspergillus Species and Rare Molds: A Phase 2, Open-Label Study (AEGIS). Clin Infect Dis 2025 Apr 9:ciaf185. doi: 10.1093.
PMID: 40203286